January 22, 2018 / 1:57 PM / in 20 minutes BRIEF-ImmunoPrecise To Invest In Single Cell's Foundational Technology Reuters Staff 
Jan 22 (Reuters) - Immunoprecise Antibodies Ltd: 
* IMMUNOPRECISE TO STRATEGICALLY INVEST IN FOUNDATIONAL NEXT GENERATION ANTIBODY DISCOVERY TECHNOLOGY 
* IMMUNOPRECISE ANTIBODIES - ‍AGREED TO INVEST $5 MILLION IN EXPANSION & DEVELOPMENT OF PRODUCTION CAPABILITY FOR SINGLE CELL‘S FOUNDATIONAL TECHNOLOGY​ 
* IMMUNOPRECISE ANTIBODIES - INVESTMENT WILL RESULT IN CO OWNING ABOUT 10% OF ISSUED AND OUTSTANDING SHARES OF SINGLE CELL Source text for Eikon: Further company coverage: